A carregar...
Overcoming resistance to anti-EGFR therapy — where do we stand?
In the past few years, the mechanisms leading to an acquired resistance to anti-EGFR monoclonal antibodies became an important topic in metastatic colorectal cancer research. In this commentary, we briefly summarize the latest update to this field by Arena and colleagues, and discuss promising new d...
Na minha lista:
| Publicado no: | Nat Rev Gastroenterol Hepatol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7493690/ https://ncbi.nlm.nih.gov/pubmed/27006256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrgastro.2016.52 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|